Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREMI: Prednisolone in Unexplained Recurrent Miscarriage
NCT05725512Phase 4Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2024
- Primary completion
- Jul 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisolone in recurrent miscarriage (RPL), sponsored by Leiden University Medical Center. Started Jan 2024; status: recruiting.
02
Drugs
prednisolone
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on NCT05725512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05725512.